| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/08/2007 | CA2620886A1 Cellular libraries of peptide sequences (clips) and methods of using the same |
| 03/08/2007 | CA2620826A1 Novel enhanced processes for drug testing including neoplasmic tissue slices and products thereby |
| 03/08/2007 | CA2620774A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | CA2620528A1 Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states |
| 03/08/2007 | CA2620403A1 Complex formation method and separation method |
| 03/08/2007 | CA2620382A1 Cell for testing fluids at elevated pressures |
| 03/08/2007 | CA2620351A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 03/08/2007 | CA2620117A1 Glycerol channel gene and use thereof |
| 03/08/2007 | CA2620022A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 03/08/2007 | CA2619676A1 Optically fluorescent nanoparticles |
| 03/08/2007 | CA2616561A1 Therapeutic goose antibodies for treatment and prophylaxis of transmittable viral diseases |
| 03/08/2007 | CA2615278A1 Coagulation test system |
| 03/08/2007 | CA2614771A1 Analyte test system using non-enzymatic analyte recognition elements |
| 03/08/2007 | CA2605228A1 Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 03/08/2007 | CA2604434A1 Multi-functional and configurable assays |
| 03/07/2007 | EP1760468A1 Method for detecting a biochemical interaction |
| 03/07/2007 | EP1760467A1 Optically fluorescent nanoparticles |
| 03/07/2007 | EP1760466A1 Measuring method and instrument using a cartridge |
| 03/07/2007 | EP1760465A1 Device with a compressible matrix having a homogeneous flow profile |
| 03/07/2007 | EP1760463A2 Method and device for qualitatively and/or quantitatively determining a protein and/or peptide pattern of a liquid sample taken from the human or animal body |
| 03/07/2007 | EP1760440A1 Confocal raman spectroscopy for dermatological studies |
| 03/07/2007 | EP1760158A1 Method of assaying substance capable of changing mitochondrial membrane potential |
| 03/07/2007 | EP1760149A1 Method of constructing modified protein |
| 03/07/2007 | EP1760147A1 Crystal structures of carnitine palmitoyltransferase-2 (CPT-2) and uses thereof |
| 03/07/2007 | EP1760092A1 System for screening cells for high expression of a protein of interest |
| 03/07/2007 | EP1760087A1 Novel protein complex and use thereof |
| 03/07/2007 | EP1759761A1 Affinity particle and affinity separation method |
| 03/07/2007 | EP1759709A1 Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 03/07/2007 | EP1759326A2 Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
| 03/07/2007 | EP1759214A1 The use of cardiac hormones for diagnosing the risk of suffering from a cardiovascular complication as a consequence of cardiotoxic medication |
| 03/07/2007 | EP1759213A2 Analysis method |
| 03/07/2007 | EP1759212A1 Identification of compounds modifying a cellular response |
| 03/07/2007 | EP1759211A2 Uses of gpr100 receptor in diabetes and obesity regulation |
| 03/07/2007 | EP1759210A2 Method for preparing substrates having immobilized molecules and substrates |
| 03/07/2007 | EP1759209A2 Method for increasing the dynamic measuring range of test elements, especially immunological test elements, that are based on specific bonding reactions |
| 03/07/2007 | EP1759208A1 Identification of antibody-producing cells |
| 03/07/2007 | EP1759207A1 P4has as modifiers of the igfr pathway and methods of use |
| 03/07/2007 | EP1759206A2 Cdk9 as modifier of the igf pathway and methods of use |
| 03/07/2007 | EP1759205A1 Pgds as modifiers of the pten pathway and methods of use |
| 03/07/2007 | EP1759204A1 Luminescent compounds having a functionalised linker arm used in the bioconjugation and labelling of biomolecules |
| 03/07/2007 | EP1759203A2 Methods and means for treatment of osteoarthritis |
| 03/07/2007 | EP1759202A1 Sensor-dispensing instrument and method of using the same |
| 03/07/2007 | EP1759201A2 System for monitoring physiological characteristics according to the user biological state |
| 03/07/2007 | EP1759200A1 Method and device for controlling the positioning of a biological element on a support |
| 03/07/2007 | EP1759199A2 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues |
| 03/07/2007 | EP1759198A1 System and method for characterising grinding material in a roller mill |
| 03/07/2007 | EP1759190A1 Physical quantity, particularly humidity detection device, and related detecting method |
| 03/07/2007 | EP1759187A1 Ir-sensor, particularly a co2- sensor |
| 03/07/2007 | EP1759186A2 Sensor constructs and detection methods |
| 03/07/2007 | EP1759185A2 Vial presence indicator for vial-bearing rack |
| 03/07/2007 | EP1759020A2 Acacs as modifiers of the igf pathway and methods of use |
| 03/07/2007 | EP1759014A2 Method for determining biophysical properties |
| 03/07/2007 | EP1759010A2 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 03/07/2007 | EP1759009A1 Multigene predictors of response to chemotherapy |
| 03/07/2007 | EP1759006A2 Galnts as modifiers of the igfr pathway and methods of use |
| 03/07/2007 | EP1759001A1 Bone delivery conjugates and method of using same to target proteins to bone |
| 03/07/2007 | EP1758994A2 Aldos as modifiers of the igf pathway and methods of use |
| 03/07/2007 | EP1758993A2 Pfks as modifiers of the igfr pathway and methods of use |
| 03/07/2007 | EP1758985A2 Artificial immune system: methods for making and use |
| 03/07/2007 | EP1758925A2 Recombinant icosahedral virus like particle production in pseudomonads |
| 03/07/2007 | EP1758917A1 Substituted azaporphyrins as fluorescence labels |
| 03/07/2007 | EP1758640A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 03/07/2007 | EP1758604A2 Method for improved breast milk feeding to reduce the risk of allergy |
| 03/07/2007 | EP1758594A1 Combination for inhibiting bone resorption comprising a bisphosponate (alendrona) and a vitamin d (cholecalciferol) |
| 03/07/2007 | EP1758565A2 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 03/07/2007 | EP1758562A2 Compositions and methods for bone formation and remodeling |
| 03/07/2007 | EP1758448A2 Quantitative lateral flow system and assay |
| 03/07/2007 | EP1685053B1 Method for determining the effects of a yarn |
| 03/07/2007 | EP1654163B1 Transport container |
| 03/07/2007 | EP1642121B1 Drift compensation for an impedimetric exhaust gas sensor by variable bias voltage |
| 03/07/2007 | EP1641923A4 Nadks as modifiers of branching morphogenesis and methods of use |
| 03/07/2007 | EP1613961A4 Surface receptor complexes as biomarkers |
| 03/07/2007 | EP1588158B1 Measuring the quality and/or degradation of food oil, cooking appliance |
| 03/07/2007 | EP1585986B1 Surface layer affinity-chromatography |
| 03/07/2007 | EP1583964B1 Sensor dispensing device |
| 03/07/2007 | EP1554557B1 Test device for internal combustion engine |
| 03/07/2007 | EP1552008A4 Microparticle based signal amplification for the detection of analytes |
| 03/07/2007 | EP1546723A4 Reading of fluorescent arrays |
| 03/07/2007 | EP1531842A4 Regulation of cell growth by muc1 |
| 03/07/2007 | EP1430152B1 Gene and protein relating to hepatocellular carcinoma |
| 03/07/2007 | EP1416276B1 Biosensors and measurement method |
| 03/07/2007 | EP1395283B1 Heterologous protection induced by immunization with invaplex vaccine |
| 03/07/2007 | EP1362052B1 Inhibitors of cruzipain and other cysteine proteases |
| 03/07/2007 | EP1337541B1 Massive parallel method for decoding DNA and RNA |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1327149A4 Methods of high-throughput screening for internalizing antibodies |
| 03/07/2007 | EP1309719A4 Bioreactor and bioprocessing technique |
| 03/07/2007 | EP1276379A4 In situ growth, freezing and testing of cultured cells |
| 03/07/2007 | EP1269194B1 Prostate cancer markers |
| 03/07/2007 | EP1266005B1 Regulation of human lipoxin a4 receptor-like protein |
| 03/07/2007 | EP1257695B1 Biomolecules having multiple attachment moieties for binding to a substrate surface |
| 03/07/2007 | EP1210457B1 Detection of differences in nucleic acids by inhibition of spontaneous dna branch migration |
| 03/07/2007 | EP1194781B1 Method for conducting chemiluminescent binding assay |
| 03/07/2007 | EP1119414B1 Collection device for biological samples and methods of use |
| 03/07/2007 | EP1032387B1 Novel metal complexes |
| 03/07/2007 | EP1029016B1 Novel chemiluminescent labeling compounds |
| 03/07/2007 | EP1028753B2 Delivery of poly (ethylene glycol) -conjugated molecules from degradable hydrogels |
| 03/07/2007 | EP1017817B1 Mutants of thyroid stimulating hormone |
| 03/07/2007 | EP1009752B1 Novel molecules of the tango-77 related protein family and uses thereof |
| 03/07/2007 | EP1007638B1 Kcnq potassium channels and methods of modulating same |